GWPCARE Study Group. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial - Thiele, EA; Marsh, ED; French, JA (Lancet, 2018)
(10125):